Congenital mirror movement disorder
A rare neurological disorder characterized by involuntary movements on one side of the body mirroring voluntary movements on the opposite side.
| Congenital mirror movement disorder | |
|---|---|
| Synonyms | CMM disorder |
| Pronounce | |
| Field | Neurology, Medical genetics |
| Symptoms | Involuntary mirroring of intentional movements on the opposite side of the body (typically hands) |
| Complications | Motor coordination difficulties, functional limitations in daily tasks |
| Onset | Birth or early infancy |
| Duration | Lifelong |
| Types | Isolated (nonsyndromic) or syndromic forms |
| Causes | Mutations in the DACT1, RAD51, or DNAL4 genes; disruption in corticospinal tract development |
| Risks | Family history of CMM; autosomal dominant inheritance pattern |
| Diagnosis | Clinical examination, electromyography (EMG), genetic testing |
| Differential diagnosis | Parkinson's disease, Klippel–Feil syndrome, Moebius syndrome |
| Prevention | None |
| Treatment | Supportive care, occupational therapy, physical therapy |
| Medication | None specific; botulinum toxin in some cases |
| Prognosis | Typically stable; symptoms may improve with therapy but usually persist |
| Frequency | Rare |
| Deaths | Not life-threatening |
Congenital mirror movement disorder (CMM) is a rare neurological disorder characterized by involuntary movements on one side of the body that mirror voluntary movements on the opposite side. This condition is present from birth and is typically noticed in early childhood.
Presentation[edit]
Individuals with congenital mirror movement disorder exhibit involuntary movements that occur simultaneously with intentional movements on the opposite side of the body. For example, when a person with CMM moves their right hand, their left hand may involuntarily perform the same movement. These mirror movements are most commonly observed in the upper limbs, particularly the hands and fingers, but can also affect the lower limbs.
Pathophysiology[edit]
The exact cause of congenital mirror movement disorder is not fully understood, but it is believed to involve abnormal development of the nervous system. In typical development, the motor cortex in the brain controls movements on the opposite side of the body. In individuals with CMM, there may be abnormal connections or lack of proper inhibition between the two hemispheres of the brain, leading to simultaneous activation of both sides.
Genetics[edit]
Congenital mirror movement disorder can be inherited in an autosomal dominant pattern, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder. Mutations in the DCC gene have been associated with CMM. The DCC gene is involved in the development of the nervous system, particularly in the guidance of neurons and the formation of neural circuits.
Diagnosis[edit]
Diagnosis of congenital mirror movement disorder is primarily clinical, based on the observation of mirror movements. Neurological examination and electromyography (EMG) may be used to assess the extent and nature of the movements. Genetic testing can confirm the presence of mutations associated with the disorder.
Management[edit]
There is currently no cure for congenital mirror movement disorder. Management focuses on minimizing the impact of the disorder on daily activities. Physical therapy and occupational therapy may help improve motor skills and coordination. In some cases, botulinum toxin injections have been used to reduce the severity of mirror movements.
Prognosis[edit]
The prognosis for individuals with congenital mirror movement disorder varies. While the condition is lifelong, many individuals learn to adapt to the involuntary movements and lead normal lives. The severity of the disorder can vary widely among affected individuals.
Related pages[edit]
External links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian